RELAPSED OR RESISTANT ACUTE LEUKAEMIAS

Clinical trials for RELAPSED OR RESISTANT ACUTE LEUKAEMIAS explained in plain language.

Never miss a new study

Get alerted when new RELAPSED OR RESISTANT ACUTE LEUKAEMIAS trials appear

Sign up with your email to follow new studies for RELAPSED OR RESISTANT ACUTE LEUKAEMIAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for hard-to-treat leukaemias? early trial of LBS-007 begins

Disease control Recruiting now

This study tests a new drug called LBS-007 in adults with acute leukaemia (AML or ALL) that has returned or not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it helps control the disease. About 90 participants will…

Matched conditions: RELAPSED OR RESISTANT ACUTE LEUKAEMIAS

Phase: PHASE1, PHASE2 • Sponsor: Lin BioScience, Inc • Aim: Disease control

Last updated May 04, 2026 16:23 UTC

RELAPSED OR RESISTANT ACUTE LEUKAEMIAS

Get alerted when new RELAPSED OR RESISTANT ACUTE LEUKAEMIAS trials appear

New hope for hard-to-treat leukaemias? early trial of LBS-007 begins